SmofKabiven special EF 1012 ml, Infusionsemulsion

7680668590025 CH-66859 Infusionsemulsion
SmofKabiven special EF 1012 ml, Infusionsemulsion
SmofKabiven special EF 1012 ml, Infusionsemulsion
SmofKabiven special EF 1012 ml, Infusionsemulsion
1 / 3
google

Article details

Package size
4 x 1012
Selling units
4
Measure
ml
Galenic form
Infusionsemulsion
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/09/2023
Summary of Product Characteristics
Français
29/09/2023
Summary of Product Characteristics
Italien
29/09/2023

Detailed composition

Substance Quantity Type Category
sojae oleum raffinatum
8.8 G Substance Wirkstoff (Principe actif)
glucosum
85.7 G Substance Wirkstoff (Principe actif)
alaninum
9.3 G Substance Wirkstoff (Principe actif)
carbohydrata
84.8 G Substance Wirkstoff (Principe actif)
aminoacida
65.55 G Substance Wirkstoff (Principe actif)
glucosum monohydricum
- Substance WIZUS
triglycerida media
8.8 G Substance Wirkstoff (Principe actif)
argininum
7.9 G Substance Wirkstoff (Principe actif)
glycinum
7.3 G Substance Wirkstoff (Principe actif)
nitrogenia
10.5 G Substance Wirkstoff (Principe actif)
olivae oleum raffinatum
7.3 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum
- Substance HNIDK
piscis oleum
4.4 G Substance Wirkstoff (Principe actif)
materia crassa
28.7 G Substance Wirkstoff (Principe actif)
histidinum
1.9 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
isoleucinum
3.3 G Substance Wirkstoff (Principe actif)
int-rac-alpha-tocopherolum
- Substance HIMDK
phospholipida ex ovo purificata
- Substance HNIDK
leucinum
4.8 G Substance Wirkstoff (Principe actif)
glycerolum
- Substance HNIDK
lysinum anhydricum
4.4 G Substance Wirkstoff (Principe actif)
natrium
3.93 MG Substance HBESI
lysini acetas
- Substance WIZUS
natrii oleas
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
methioninum
2.8 G Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
phenylalaninum
3.4 G Substance Wirkstoff (Principe actif)
prolinum
7.4 G Substance Wirkstoff (Principe actif)
serinum
4.3 G Substance Wirkstoff (Principe actif)
taurinum
0.66 G Substance Wirkstoff (Principe actif)
threoninum
2.9 G Substance Wirkstoff (Principe actif)
tryptophanum
1.3 G Substance Wirkstoff (Principe actif)
tyrosinum
0.3 G Substance Wirkstoff (Principe actif)
valinum
4.1 G Substance Wirkstoff (Principe actif)
acidum aceticum glaciale
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
66859
Drug name
SmofKabiven special EF, Infusionsemulsion
Galenic form
EMUI
ATC Code
B05BA10
Authorization status
Z
Dispensing category
B
First authorization
11/12/2018
Authorization expiration date
31/12/9999
IT Number
07.01.2.
Domain
Human medicine
Field of application
Parenterale Ernährung

Package details

Description (FR)
SMOFKABIVEN special EF émuls perf 1012ml 4 pce
Description (DE)
SMOFKABIVEN special EF Inf Emuls 1012ml 4 Stk
Market launch
11/12/2018
Narcotic (BTM)
No

Other package sizes (1)

SMOFKABIVEN special EF émuls perf 1518ml sac 4 pce
4 x 1518 ML
GTIN: 7680668590049
View
Buy us a coffee Explore the data